CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 8-K Event Auditor change · Executive or director change
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy Director bought 9,878 shares at $6.46 ($63,843)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- S-1 Offering Registration Statement
- 10-Q/A Report 10-Q/A
- 8-K Event Restatement
- 8-K Event Material agreement · Unregistered share sale · Director nominations · Other events
- 4 Open-market buy 10% owner bought 160,000 shares at $6.25 ($1,000,000)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 4 Grant or award Director acquired 32,000 shares (grant or award)
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 28 of 63 · 1,250 filings